Sandler Capital Management Astrazeneca PLC Transaction History
Sandler Capital Management
- $870 Million
- Q4 2024
A detailed history of Sandler Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Sandler Capital Management holds 4,000 shares of AZN stock, worth $294,000. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$294,000
Previous $311,000
15.76%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,369Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.44 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.01 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.76 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.43 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...